HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Blue Toe Syndrome

A condition that is caused by recurring atheroembolism in the lower extremities. It is characterized by cyanotic discoloration of the toes, usually the first, fourth, and fifth toes. Discoloration may extend to the lateral aspect of the foot. Despite the gangrene-like appearance, blue toes may respond to conservative therapy without AMPUTATION, SURGICAL.
Also Known As:
Syndrome, Blue Toe
Networked: 57 relevant articles (4 outcomes, 2 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Ischemia
2. Acute Kidney Injury (Acute Renal Failure)
3. Renal Insufficiency (Renal Failure)
4. Livedo Reticularis
5. Purpura

Experts

1. Criado, Paulo Ricardo: 2 articles (08/2020 - 01/2020)
2. Kronzon, Itzhak: 2 articles (06/2012 - 11/2011)
3. Saric, Muhamed: 2 articles (06/2012 - 11/2011)
4. Freeman, M B: 2 articles (09/2001 - 02/2001)
5. Goldman, M H: 2 articles (09/2001 - 02/2001)
6. Stevens, S L: 2 articles (09/2001 - 02/2001)
7. Timaran, C H: 2 articles (09/2001 - 02/2001)
8. Fourgeaud, C: 1 article (09/2022)
9. Michon-Pasturel, U: 1 article (09/2022)
10. Vignes, S: 1 article (09/2022)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Blue Toe Syndrome:
1. CholesterolIBA
2. Alprostadil (Muse)FDA LinkGeneric
3. oxidized low density lipoproteinIBA
4. AnticoagulantsIBA
5. CreatinineIBA
6. Antiphospholipid AntibodiesIBA
7. Warfarin (Coumadin)FDA LinkGeneric
8. Pharmaceutical PreparationsIBA
9. Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
10. Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA

Therapies and Procedures

1. Sympathectomy (Sympathectomies)
2. Blood Component Removal (Apheresis)
3. Therapeutics
4. Limb Salvage
5. Stents